Prenatal maternal stress hormones, risk for hypertension, and the neonatal pain response: Comment on France et al., ''Maternal family history of hypertension attenuates neonatal pain response"
In this volume, France et al. [5] report reduced pain response in neonates with a maternal family history of hypertension. Their results add a radical new twist to the mysterious link between hypoalgesia and blood pressure dysregulation in the early stages of hypertension. France et al. [5] suggest that maternal transmission of hypertension-associated hypoalgesia could result from mitochondrial DNA. However, there is a compelling need to also consider environmental mechanisms of maternal transmission, especially the effects of prenatal maternal stress hormones on fetal neurodevelopment.
The prenatal intrauterine environment is a rich and dynamic milieu that can influence the development of complex fetal regulatory systems, including the mechanisms that control blood pressure and responses to pain. Citing the correlation of birth weight with subsequent adult blood pressure, Barker [2] hypothesizes that reduced availability of nutrients during fetal development causes relatively permanent changes in renal function. However, the action of maternal stress hormones suggests an additional link between maternal risk for hypertension and neonatal pain response.
Growing evidence suggests that the maternal stress hormones can affect the developing fetus in ways that could promote vulnerability to chronic disease. For example, young adult men and women who are at risk for hypertension have reduced pain sensitivity and exaggerated blood pressure reactivity during psychological stress [6] . The exaggerated blood pressure reactivity appears to result from diminished central opioidergic inhibition of the sympathoadrenomedullary and hypothalamic-pituitary-adrenocortical axes [9] . This produces periodic abnormal elevations in plasma levels of epinephrine, norepinephrine and cortisol in persons at risk for hypertension [1, 9] . The associated hypoalgesia is complex, and probably involves both opioid and non-opioid pathways [4, 6] . During pregnancy, the neuroendocrine profile of women at risk for hypertension may have direct consequences on the developing fetal nervous system. Studies of stress during pregnancy support the links between maternal blood pressure reactivity and fetal development. For example, we found that increased maternal blood pressure response to stress during pregnancy predicts subsequent birth outcome, including reduced birth weight, gestational age, and rate of fetal weight gain [7] . The reduced rate of fetal weight gain indicates an influence on the fetal development, not simply early onset of labor. Thus, maternal blood pressure control mechanisms can have a profound influence on the developing fetus. Minutes Fig. 1 . The effect of maternal stress on fetal heart rate. Simultaneous minute by minute changes in fetal heart rate and maternal heart rate (bpm) before, during and after maternal performance on a stressful mental arithmetic challenge. 
